Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdVEGF-D gene therapy for refractory angina
NCT03039751Phase 2Completed
- Sponsor
- Kuopio University Hospital
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Gene Editing, Gene Silencing, Viral Vectors
- Countries
- 2
01
Overview
A Phase 2 trial of AdvVEGF-D in angina pectoris, sponsored by Kuopio University Hospital. Started Oct 2019; status: completed.
02
Drugs
AdvVEGF-D
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT03039751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03039751.